Selected research
Industry Research
Omeprazole Industry Research Report 2026
Market perspective
The global Omeprazole market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Omeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Omeprazole is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Omeprazole is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Omeprazole include Teva, Sandoz, Mylan, AstraZeneca AB, Stada, Saval Pharmaceutical, Sanofi, Mepha, KernPharm and Garmish Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Omeprazole market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Omeprazole Market by Company
Teva
Sandoz
Mylan
AstraZeneca AB
Stada
Saval Pharmaceutical
Sanofi, Mepha
KernPharm
Garmish Pharmaceuticals
CQ Lummy
Blaskov
Actavis
Omeprazole Segment by Type
Injection
Tablet
Capsule
Omeprazole Segment by Application
Children
Adult
Omeprazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omeprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omeprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omeprazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Omeprazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Omeprazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Omeprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Capsule
Applications
- Children
- Adult
Companies covered
- Teva
- Sandoz
- Mylan
- AstraZeneca AB
- Stada
- Saval Pharmaceutical
- Sanofi, Mepha
- KernPharm
- Garmish Pharmaceuticals
- CQ Lummy
- Blaskov
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Omeprazole Market Size (2021-2032)
- 2.2.2 Global Omeprazole Sales (2021-2032)
- 2.2.3 Global Omeprazole Market Average Price (2021-2032)
- 2.3 Omeprazole by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablet
- 2.3.4 Capsule
- 2.4 Omeprazole by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Children
- 2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Omeprazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Omeprazole Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Omeprazole Revenue of Manufacturers (2021-2026)
- 3.4 Global Omeprazole Average Price by Manufacturers (2021-2026)
- 3.5 Global Omeprazole Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Omeprazole, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Omeprazole, Product Type & Application
- 3.8 Global Manufacturers of Omeprazole, Established Date
- 3.9 Global Omeprazole Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Omeprazole Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Omeprazole Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Omeprazole Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 AstraZeneca AB
- 4.4.1 AstraZeneca AB Company Information
- 4.4.2 AstraZeneca AB Business Overview
- 4.4.3 AstraZeneca AB Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca AB Omeprazole Product Portfolio
- 4.4.5 AstraZeneca AB Recent Developments
- 4.5 Stada
- 4.5.1 Stada Company Information
- 4.5.2 Stada Business Overview
- 4.5.3 Stada Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Stada Omeprazole Product Portfolio
- 4.5.5 Stada Recent Developments
- 4.6 Saval Pharmaceutical
- 4.6.1 Saval Pharmaceutical Company Information
- 4.6.2 Saval Pharmaceutical Business Overview
- 4.6.3 Saval Pharmaceutical Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Saval Pharmaceutical Omeprazole Product Portfolio
- 4.6.5 Saval Pharmaceutical Recent Developments
- 4.7 Sanofi, Mepha
- 4.7.1 Sanofi, Mepha Company Information
- 4.7.2 Sanofi, Mepha Business Overview
- 4.7.3 Sanofi, Mepha Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi, Mepha Omeprazole Product Portfolio
- 4.7.5 Sanofi, Mepha Recent Developments
- 4.8 KernPharm
- 4.8.1 KernPharm Company Information
- 4.8.2 KernPharm Business Overview
- 4.8.3 KernPharm Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 KernPharm Omeprazole Product Portfolio
- 4.8.5 KernPharm Recent Developments
- 4.9 Garmish Pharmaceuticals
- 4.9.1 Garmish Pharmaceuticals Company Information
- 4.9.2 Garmish Pharmaceuticals Business Overview
- 4.9.3 Garmish Pharmaceuticals Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Garmish Pharmaceuticals Omeprazole Product Portfolio
- 4.9.5 Garmish Pharmaceuticals Recent Developments
- 4.10 CQ Lummy
- 4.10.1 CQ Lummy Company Information
- 4.10.2 CQ Lummy Business Overview
- 4.10.3 CQ Lummy Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CQ Lummy Omeprazole Product Portfolio
- 4.10.5 CQ Lummy Recent Developments
- 4.11 Blaskov
- 4.11.1 Blaskov Company Information
- 4.11.2 Blaskov Business Overview
- 4.11.3 Blaskov Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Blaskov Omeprazole Product Portfolio
- 4.11.5 Blaskov Recent Developments
- 4.12 Actavis
- 4.12.1 Actavis Company Information
- 4.12.2 Actavis Business Overview
- 4.12.3 Actavis Omeprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Actavis Omeprazole Product Portfolio
- 4.12.5 Actavis Recent Developments
5 Global Omeprazole Market Scenario by Region
- 5.1 Global Omeprazole Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Omeprazole Sales by Region: 2021-2032
- 5.2.1 Global Omeprazole Sales by Region: 2021-2026
- 5.2.2 Global Omeprazole Sales by Region: 2027-2032
- 5.3 Global Omeprazole Revenue by Region: 2021-2032
- 5.3.1 Global Omeprazole Revenue by Region: 2021-2026
- 5.3.2 Global Omeprazole Revenue by Region: 2027-2032
- 5.4 North America Omeprazole Market Facts & Figures by Country
- 5.4.1 North America Omeprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Omeprazole Sales by Country (2021-2032)
- 5.4.3 North America Omeprazole Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Omeprazole Market Facts & Figures by Country
- 5.5.1 Europe Omeprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Omeprazole Sales by Country (2021-2032)
- 5.5.3 Europe Omeprazole Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Omeprazole Market Facts & Figures by Country
- 5.6.1 Asia Pacific Omeprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Omeprazole Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Omeprazole Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Omeprazole Market Facts & Figures by Country
- 5.7.1 South America Omeprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Omeprazole Sales by Country (2021-2032)
- 5.7.3 South America Omeprazole Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Omeprazole Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Omeprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Omeprazole Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Omeprazole Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Omeprazole Sales by Type (2021-2032)
- 6.1.1 Global Omeprazole Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Omeprazole Sales Market Share by Type (2021-2032)
- 6.2 Global Omeprazole Revenue by Type (2021-2032)
- 6.2.1 Global Omeprazole Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Omeprazole Revenue Market Share by Type (2021-2032)
- 6.3 Global Omeprazole Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Omeprazole Sales by Application (2021-2032)
- 7.1.1 Global Omeprazole Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Omeprazole Sales Market Share by Application (2021-2032)
- 7.2 Global Omeprazole Revenue by Application (2021-2032)
- 7.2.1 Global Omeprazole Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Omeprazole Revenue Market Share by Application (2021-2032)
- 7.3 Global Omeprazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Omeprazole Value Chain Analysis
- 8.1.1 Omeprazole Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Omeprazole Production Mode & Process
- 8.2 Omeprazole Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Omeprazole Distributors
- 8.2.3 Omeprazole Customers
9 Global Omeprazole Analyzing Market Dynamics
- 9.1 Omeprazole Industry Trends
- 9.2 Omeprazole Industry Drivers
- 9.3 Omeprazole Industry Opportunities and Challenges
- 9.4 Omeprazole Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst